Skip to Content

Dalliah M. Black, M.D., F.A.C.S.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Surgical Oncology, Division of Surgery, Department of Surgical Oncology, Division of Surgey,The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement

Dalliah M. Black, MD, FACS is an Assistant Professor of Surgical Oncology at the University of Texas MD Anderson Cancer Center in Houston. She earned her medical degree at the University of North Carolina School of Medicine in Chapel Hill where she also completed her residency in General Surgery. Her fellowship training in Breast Surgical Oncology was completed at Massachusetts General Hospital in Boston. 


Dr. Black’s clinical interests include evaluating barriers to medical care in the underserved, disparities in breast cancer outcomes, and biologic differences in breast cancers. Her surgical research, including evaluating the natural history of small HER2 breast cancers, determining the validity of the use of pre-operative MRI in detecting breast cancer versus the use of sentinel lymph node biopsy in high risk patients undergoing prophylactic mastectomy, and evaluating the accuracy of intra-operative technetium injection for sentinel lymph node identification has resulted in national presentations, including the Society of Surgical Oncology and the American College of Surgeons, and publications in the Annals of Surgical Oncology, Archives of Surgery, and Surgery.


Dr. Black has a strong interest in patient education and the patient-physician relationship. She has received several awards for her community efforts. She has also served on the board of directors for the breast cancer support group, The Red Devils, as a medical advisor for Sisters Network, and served on the state of Maryland Breast Cancer Control Commission to improve access and treatment. She is a Fellow of the American College of Surgeons and a member of the American Society of Breast Surgeons and Society of Surgical Oncology.

Education & Training

Degree-Granting Education

1998 University of North Carolina School of Medicine, Chapel Hill, NC, MD, Medicine
1994 University of North Carolina at Chapel Hill, Chapel Hill, NC, BS, Biology

Postgraduate Training

7/2005-7/2006 Clinical Fellowship, Breast Surgical Oncology, Massachusetts General Hospital/Brigham & Women's Hospital, Boston, MA
6/1999-6/2005 Clinical Residency, General Surgery, University of North Carolina Hospitals, Chapel Hill, NC
6/1998-6/1999 Clinical Internship, General Surgery, Thomas Jefferson University Hospital, Philadelphia, PA

Board Certifications

2006 American Board of Surgery


Academic Appointments

Breast Surgeon, The Sullivan Breast Center, Division of Surgery, The Sullivan Breast Center, Division of Surgery, Sibley Memorial Hospital, Washington, DC, 7/2010-10/2011
Breast Surgeon, The Hoffberger Breast Center, Division of Surgery, The Hoffberger Breast Center, Division of Surgery,Mercy Medical Center, Baltimore, MD, 2/2008-6/2010
Assistant Professor, The Yale Breast Center, Division of Surgery, Yale University School of Medicine, New Haven, CT, 8/2006-1/2008

Professional Memberships

American College of Surgeons
Fellow, 2008-present
American Society of Breast Surgeons
Member, 2006-present
Maryland Comprehensive Cancer Control
Breast Cancer Committee Member, 2010-2011
Sisters Network, Baltimore Chapter
Medical Advisory Board Member, 2009-2011
Society of Surgical Oncology
Member, 2006-present
The Red Devils
Member of the Board of Directors, 2009-2010

Selected Publications

Peer-Reviewed Original Research Articles

1. Grube BJ, Christy CJ, Black D, Martel M, Harris L, Weidhaas J, Digiovanna MP, Chung G, Abu-Khalaf MM, Miller KD, Higgins SA, Philpotts L, Tavassoli FA, Lannin DR. Breast sentinel lymph node dissection before preoperative chemotherapy. Arch Surg 143(7):692-9; discussion 699-700, 7/2008. PMID: 18645113.
2. Dominguez FJ, Golshan M, Black DM, Hughes KS, Gadd MA, Christian R, Lesnikoski BA, Specht M, Michaelson J, Smith BL. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ. Ann Surg Oncol 15(1):268-73, 1/2008. e-Pub 9/2007. PMID: 17891441.
3. Black D, Lyman S, Qian T, Lemasters JJ, Rippe RA, Nitta T, Kim JS, Behrns KE. Transforming growth factor beta mediates hepatocyte apoptosis through Smad3 generation of reactive oxygen species. Biochimie 89(12):1464-73, 12/2007. e-Pub 9/2007. PMCID: PMC2151473.
4. Lannin DR, Grube B, Black DS, Ponn T. Breast tattoos for planning surgery following neoadjuvant chemotherapy. Am J Surg 194(4):518-20, 10/2007. PMID: 17826070.
5. Black D, Specht M, Lee JM, Dominguez F, Gadd M, Hughes K, Rafferty E, Smith B. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy. Ann Surg Oncol 14(9):2477-84, 9/2007. e-Pub 6/2007. PMID: 17587091.
6. Dominguez FJ, Lawrence C, Halpern EF, Drohan B, Grinstein G, Black DM, Smith BL, Gadd MA, Specht M, Kopans DB, Moore RH, Hughes SS, Roche CA, Hughes KS. Accuracy of self-reported personal history of cancer in an outpatient breast center. J Genet Couns 16(3):341-5, 6/2007. e-Pub 5/2007. PMID: 17508275.
7. Dominguez FJ, Black DM, Kawaguchi AL, O'Malley CA, Hughes KS. Elastic stay hooks and self-retaining retractor technique for mastectomy skin flaps. Surgery 141(2):272-4, 2/2007. e-Pub 8/2006. PMID: 17263986.
8. Black D, Smith BL. Surgical treatment options in young women with breast cancer. Breast Dis 23:37-45, 2006, 2005. PMID: 16823165.
9. Black D, Bird MA, Samson CM, Lyman S, Lange PA, Schrum LW, Qian T, Lemasters JJ, Brenner DA, Rippe RA, Behrns KE. Primary cirrhotic hepatocytes resist TGFbeta-induced apoptosis through a ROS-dependent mechanism. J Hepatol 40(6):942-51, 6/2004. PMID: 15158334.
10. Black D, Bird MA, Hayden M, Schrum LW, Lange P, Samson C, Hatano E, Rippe RA, Brenner DA, Behrns KE. TNF alpha-induced hepatocyte apoptosis is associated with alterations of the cell cycle and decreased stem loop binding protein. Surgery 135(6):619-28, 6/2004. PMID: 15179368.
11. Black D, Lyman S, Heider TR, Behrns KE. Molecular and cellular features of hepatic regeneration. J Surg Res 117(2):306-15, 4/2004. PMID: 15047136.
12. Bird MA, Black D, Lange PA, Samson CM, Hayden M, Behrns KE. NFkappaB inhibition decreases hepatocyte proliferation but does not alter apoptosis in obstructive jaundice. J Surg Res 114(2):110-7, 10/2003. PMID: 14559434.
13. Black DM, Behrns KE. A scientist revisits the atrophy-hypertrophy complex: hepatic apoptosis and regeneration. Surg Oncol Clin N Am 11(4):849-64, 10/2002. PMID: 12607575.
14. Black D, Reutter J, Johnson M, Fair J, Woosley J, Gerber D. Liver transplantation in Ellis-van Creveld syndrome: a case report. Pediatr Transplant 6(3):255-9, 6/2002. PMID: 12100513.
15. Schrum LW, Black D, Iimuro Y, Rippe RA, Brenner DA, Behrns KE. c-Jun does not mediate hepatocyte apoptosis following NFkappaB inhibition and partial hepatectomy. J Surg Res 88(2):142-9, 2/2000. PMID: 10644480.


1. Black DM, Hunt KK, Mittendorf EA. Long Term Outcomes Reporting the Safety of Breast Conserving Therapy Compared to Mastectomy: 20-year Results of EORTC 10801. Gland Surgery, 2012.


1. Christy C, Grube B, Black DM, Thorsteinsson D, Offor O, Lannin D. Factors That Influence the Rate of Re-excision Following Lumpectomy for Breast Cancer. American Society of Breast Surgeons, 4/2008.
2. Black DM, Golshan M, Christian R, Bakhlis F, Dominguez F, Smith B, Lesnikoski B. Post-Operative Outcomes of Mastectomy with Breast Tumescence Infiltration. San Antonio Breast Cancer Symposium, 12/2006.
3. Black DM, Younger J. Martei Y, Michaelson J, Dominguez F, Bhan A, Burstein H, Winer E, Goss P, Smith B. Recurrence risk in T1a-b, node negative, HER2 positive breast cancer. San Antonio Breast Cancer Symposium, 12/2006.
4. Dominguez FJ, Golshan M, Black DM, Hughes KS, Gadd MA, Rhei E, Christian R, Lesnikoski BA, Specht M, Michaelson J, Smith BL. Review of 517 Sentinel Node Biopsies Performed During Simple Mastectomy: Findings and Incidence of Positive Non-Sentinel Lymph Nodes. American Society of Breast Surgeons, 4/2006.
5. Dominguez FJ, Golshan M, Black DM, Hughes KS, Gadd MA, Rhei E, Christian R, Beth-Ann Lesnikoski BL, Specht M, Michaelson J and Smith BL. Sentinel Node Biopsy is Important in Mastectomy for Ductal Carcinoma in Situ. Society of Surgical Oncology, 3/2006.
6. Black DM, Lyman S. Qian T, Lemasters J, Rippe R, Behrns K. Transforming Growth Factor beta1-Induced Hepatocyte Apoptosis is Mediated by Smad3-Dependent Acute Generation of Reactive Oxygen Species. American Association for the Study of Liver Diseases, 10/2003.
7. Black DM, Schrum L, Lyman S, Behrns K. TNFα-Induced Hepatocyte Apoptosis Is Associated With S-Phase Block and Decreased Stem-Loop Binding Protein. Digestive Disease Week, 5/2003.
8. Lyman S, Black DM, Behrns K. Functional Gene Expression Analysis of Cirrhotic Hepatocytes that Display Decreased Sensitivity to Apoptosis. American Association for the Study of Liver Diseases, 11/2002.
9. Black DM, Lawler C, Walker Q, Eckerman D, Nichols D, Mailman R. D1 Receptors, cAMP Synthesis, and the Amphetamine Discriminative Stimulus. Society for Neuroscience National Meeting, 1994.
10. Walker Q, Black DM, Eckerman D, Nichols D, Mailman R. Behavioral and Pharmacological Determinants of D1 Dopamine Agonist Substitution for the Discriminative Stimulus Induced by Dihydrexidine. Society for Neuroscience National Meeting, 1993.
11. Black DM, Walker Q, Eckerman D, Nichols D, Mailman R. Dopamine D2 Discriminative Stimulus Properties of Dihydrexidine and its Analog, N-n-Propyl Dihydrexidine. North Carolina Society for Neuroscience, 1993.

Grant & Contract Support

Title: Examine disparities in breast cancer evaluation across socioeconomic lines at Yale School of Medicine, -
Funding Source: The Ethel F. Donaghue Women's Health Investigator Program at Yale
Role: Principal Investigator
Duration: 7/1/2007 - 7/1/2009

Last updated: 7/15/2014